News & Recognition
WHAT’S HAPPENING
Explore the latest news, events, announcements and stories from Rochon Genova.
-
Case Updates
Update: The first of 3,000 actions relating to Actos goes to trial in the U.S.
-
Case Updates
Class action against SNC-Lavalin Group Certified: Notice of certification and authorization and leave to proceed with statutory secondary market misrepresentation claims granted by Ontario and Quebec Courts
-
Case Updates
Certification Record Filed in Class Action Commenced Against Diabetes Drug Manufacturers and Distributors: ACTOS Users Are at Heightened Risk of Developing Bladder Cancer
-
Case Updates
Recours collectif intenté contre les fabricants et distributeurs d’un médicament contre le diabète : un Québecois auquel ACTOS était prescrit est touché par le cancer de la vessie
-
Case Updates
Quebec Class Action Commenced Against Diabetes Drug Manufacturers and Distributors: Quebec Man Prescribed ACTOS Contracts Bladder Cancer
-
Case Updates
Update: SNC-Lavalin Group Inc.
-
Case Updates
J&J Tells Judge It Will Stop Sales of Vaginal Implants
-
Case Updates
Johnson & Johnson Halts Transvaginal Mesh Sales
-
Case Updates
Investors Launch Class Action Against SNC-Lavalin and Its Directors and Officers: Lawsuit seeks $1.5 billion in compensation, citing misrepresentations in relation to company’s governance practices
-
Case Updates
Trapeze Asset Management Inc.
-
Case Updates
CTV airs report on patients questioning safety of metal hip replacements
-
Case Updates
Canadian Class Action Commenced against Johnson & Johnson
-
Case Updates
Immigration Conference in Caracas, Venezuela – January 29, 2012 #4
-
Case Updates
Immigration Conference in Caracas, Venezuela – January 29, 2012
-
Case Updates
Immigration Conference in Caracas, Venezuela – January 29, 2012 #3
CONTACT OUR TEAM TO UNDERSTAND YOUR OPTIONS
Contact our team to understand your options and get clear next steps. Our services are available in English, Bengali, Farsi, French, Greek, Hungarian, Italian, Portuguese, Punjabi and Spanish.
